HolderBook

AEGLEA BIOTHERAPEUTICS INC (AGLE)

Institutional ownership reported to the SEC as of Q1 2024, across 21 quarters.

1
Reporting holders
$16.4M
Reported value
0.0%
Held as options
-2
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
Yu Fan$16.4M737,00022.68%newNEW

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q1 20241$16.4M737,0001000.0%
Q3 20233$4.0M318,4860030.0%
Q2 202337$30.9M68,694,53214380.0%
Q1 202333$8.7M30,137,2862490.0%
Q4 202237$14.0M31,198,0618970.1%
Q3 202250$23.5M44,709,37149130.0%
Q2 202259$26.3M49,419,1531220140.1%
Q1 202280$95.4M41,458,658628240.0%
Q4 202186$190.1M39,963,7881725180.2%
Q3 202177$322.6M40,576,282821240.0%
Q2 202179$289.1M41,492,292329250.1%
Q1 202185$329.0M41,504,315322320.1%
Q4 202090$326.9M41,463,829832250.2%
Q3 202093$275.2M38,821,5821722300.0%
Q2 202087$351.6M38,007,6202642130.0%
Q1 202069$95.8M20,604,767821210.0%
Q4 201968$160.3M20,976,462719170.0%
Q3 201971$154.5M20,086,184623220.0%
Q2 201977$137.1M20,039,310153490.0%
Q1 201971$162.2M20,147,5881724120.0%
Q4 201860$124.1M16,558,6921020.0%